Estelle Russek-Cohen (also published as Estelle Russek) is an American biostatistician and expert on biometrics. Formerly a professor at the University of Maryland, College Park and division director in the Center for Biologics Evaluation and Research or the Food and Drug Administration, she has retired to become a statistical consultant. [1]
Russek-Cohen graduated from Stony Brook University in 1972, with a double major in biology and mathematics. She completed her Ph.D. in biostatistics at the University of Washington in 1979. [1] [2] Her dissertation was Overspecification in linear discriminant analysis. [3]
She joined the faculty of the University of Maryland as an assistant professor in 1978, affiliated with the university's Department of Animal Sciences and Department of Microbiology. [1] [4] She eventually became full professor and director of the university's program in biometrics. She moved to the Food and Drug Administration in 2004, initially with the FDA Center for Devices and Radiological Health. In 2010 she became deputy division director for biostatistics in the Center for Biologics Evaluation and Research, and in 2014 she became division director. She left federal service in 2020 and has been principal of a consulting firm since. [1]
In 1997, the University of Maryland's College of Agriculture and Natural Resources gave Russek-Cohen their Excellence in Instruction Award. [5] Russek-Cohen was named a Fellow of the American Statistical Association in 2010. [6]
Joseph L. Fleiss was an American professor of biostatistics at the Columbia University Mailman School of Public Health, where he also served as head of the Division of Biostatistics from 1975 to 1992. He is known for his work in mental health statistics, particularly assessing the reliability of diagnostic classifications, and the measures, models, and control of errors in categorization.
Boston University School of Public Health (SPH) is one of the graduate schools of Boston University. Founded in 1976, the School offers master's- and doctoral-level programs in public health. It is located in the heart of Boston University's Medical Campus in the South End neighborhood of Boston, Massachusetts. The school has more than 8,900 alumni, 267 faculty, and 227 staff; its students hail from more than 43 countries, and its total research portfolio is worth more than $180 million. BUSPH is fully accredited by the Council on Education for Public Health and ranked 6th among Public Health Graduate Schools by U.S. News & World Report.
The Center for Drug Evaluation and Research is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act. Some biological products are also legally considered drugs, but they are covered by the Center for Biologics Evaluation and Research. The center reviews applications for brand name, generic, and over the counter pharmaceuticals, manages US current Good Manufacturing Practice (cGMP) regulations for pharmaceutical manufacturing, determines which medications require a medical prescription, monitors advertising of approved medications, and collects and analyzes safety data about pharmaceuticals that are already on the market.
Marvin Zelen was Professor Emeritus of Biostatistics in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health (HSPH), and Lemuel Shattuck Research Professor of Statistical Science. During the 1980s, Zelen chaired HSPH's Department of Biostatistics. Among colleagues in the field of statistics, he was widely known as a leader who shaped the discipline of biostatistics. He "transformed clinical trial research into a statistically sophisticated branch of medical research."
Albert P. Li is president and CEO of In Vitro ADMET Laboratories (IVAL), Columbia, Maryland, and Malden, Massachusetts. For the past three decades, Li has devoted his scientific career to the advancement of scientific concepts and technologies to accurately predict human drug properties. His research is focused on the development and application of human-based in vitro experimental systems in drug discovery and development. He is a pioneer in the isolation, cryopreservation, and culturing of human hepatocytes and their application in the evaluation of drug metabolism, drug-drug interactions, and drug toxicity.
Calvin Zippin is a cancer epidemiologist and biostatistician, and Professor Emeritus in the Department of Epidemiology and Biostatistics at the University of California School of Medicine in San Francisco (UCSF). He is a Fellow of the American Statistical Association, the American College of Epidemiology and the Royal Statistical Society of Great Britain. His doctoral thesis was the basis for the Zippin Estimator, a procedure for estimating wildlife populations using data from trapping experiments. He was a principal investigator in the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) which assesses the magnitude and nature of the cancer problem in the United States. In 1961, he created training programs for cancer registry personnel, which he conducted nationally and internationally. He carried out research on the epidemiology and rules for staging of various cancers. He received a Lifetime Achievement and Leadership Award from the NCI in 2003.
Amy Helen Herring is an American biostatistician interested in longitudinal data and reproductive health. Formerly the Carol Remmer Angle Distinguished Professor of Children's Environmental Health at the University of North Carolina at Chapel Hill, she is now Sara & Charles Ayres Distinguished Professor in the Department of Statistical Science, Global Health Institute, and Department of Biostatistics & Bioinformatics of Duke University.
Telba Zalkind Irony is a Brazilian statistician, operations researcher, and proponent of Bayesian statistics. She works at the Food and Drug Administration, where she was formerly chief of biostatistics at the Office of Device Evaluation and is now deputy directory of biostatistics and epidemiology at the Center for Biologics Evaluation and Research.
Chrystelle Lee Trump Bond was an American dancer, choreographer, dance historian, and author. Bond was the founding chair of the dance department at Goucher College. She was the co-founder and director of Chorégraphie Antique, the dance history ensemble at Goucher. Bond was a dance critic for The Baltimore Sun.
Lisa Morrissey LaVange is Professor and Chair of the Department of Biostatistics in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill where she directs the department’s Collaborative Studies Coordinating Center (CSCC), overseeing faculty, staff, and students involved in large-scale clinical trials and epidemiological studies coordinated by the center. She returned to her alma mater in 2018 after serving as the director of the Office of Biostatistics in the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER). Her career also includes 16 years in non-profit research and 10 years in the pharmaceutical industry. She served as the 2007 president of the Eastern North American Region (ENAR) of the International Biometric Society (IBS), and as the 2018 American Statistical Association (ASA) president.
Daniela M. Witten is an American biostatistician. She is a professor and the Dorothy Gilford Endowed Chair of Mathematical Statistics at the University of Washington. Her research investigates the use of machine learning to understand high-dimensional data.
Susan S. Ellenberg is an American statistician specializing in the design of clinical trials and in the safety of medical products. She is a professor of biostatistics, medical ethics and health policy in the Perelman School of Medicine at the University of Pennsylvania. She was the 1993 president of the Society for Clinical Trials and the 1999 President of the Eastern North American Region of the International Biometric Society.
Katerina Joanna Kechris is an American statistician, a professor of biostatistics and informatics in the Colorado School of Public Health, and a regional president of the International Biometric Society. Her research focuses on the use of omics data to study relations between genetics and disease.
Thomas Lumley is an Australian statistician who serves as the chair of biostatistics at the University of Auckland in New Zealand. Lumley is also a member of the "R Core Team."
Rebecca Allana Hubbard is an American biostatistician whose research interests include observational studies and the use of electronic health record data in public health analysis and decision-making, accounting for the errors in this type of data. She is a professor of biostatistics in the Perelman School of Medicine at the University of Pennsylvania.
Melody S. Goodman is an American biostatistician whose interests include social determinants of health, health literacy, and stakeholder engagement in health research. Goodman has spoken publicly about racial disparities in access to healthcare, and is an advocate for public outreach and engagement on health issues. She is an associate professor of biostatistics and associate dean for research in the New York University School of Global Public Health.
Eve Alexandra Littig Torrence is an American mathematician, a professor emerita of mathematics at Randolph–Macon College, and a former president of mathematics society Pi Mu Epsilon. She is known for her award-winning writing and books in mathematics, for her mathematical origami art, and for her efforts debunking overly broad claims regarding the ubiquity of the golden ratio.
Sofia Diana Merajver is an American-Argentine medical oncologist. She is the GreaterGood Breast Cancer Research Professor and director of the Breast and Ovarian Cancer Risk Evaluation Program at Michigan Medicine. In 2022, Merajver was elected a Fellow of the American Association for the Advancement of Science.
Sue-Jane Wang is a biostatistician at the United States Food and Drug Administration (FDA), where she works as the Biostatistics Lead and as the liaison from the Office of Biostatistics to the FDA Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program. She is also deputy division director for biometrics in the Office of Biostatistics.
Aleda Marie V. Roth is an American business scholar, operations researcher, and management scientist, specializing in supply chain management. She is the Burlington Industries Distinguished Professor of Supply Chain Management in the Clemson University College of Business and Behavioral Science.